Offer Request Form

Order list is empty

Shikari® (Q-AFA) Anti-Filgrastim ELISA w/confirmation

Enzyme immunoassay for the quantitative determination of antibodies to o Filgrastim (Fraven®) in serum and plasma with confirmation. 

This kit has been especially developed for the quantitative antibodies to Filgrastim in serum and plasma samples

Filgrastim (Fraven®) was associated to the development of anti-Filgrastim antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Fraven®. This might lead to severe complications. This kit can be efficiently used for monitoring anti-Filgrastim antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Filgrastim antibodies..

All SHIKARI® ELISA kits are suitable for biosimilar work.

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

For technical inquiry, please contact


Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 2
Spike Recovery (%) Between 85-115
Shelf Life (year) 6 months
Assay type Quantitative
Species Reactivity Human
Storage conditions Store at +4°C. Please refer to protocols.
Shipping conditions At room temperature
# File Action
Instructions For Use Download
Safety Data Sheet (SDS) Download
Validation Report Download

Publications with this drug

# File Action